How should I convert a patient from oral hydromorphone to a transdermal fentanyl patch, including appropriate dosing calculations and safety monitoring?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting Oral Hydromorphone to Transdermal Fentanyl Patch

Calculate the total daily oral hydromorphone dose, use established conversion tables to determine the appropriate fentanyl patch strength, prescribe short-acting opioid breakthrough medication for the first 8-24 hours, and monitor closely for the first 2-3 days before making any dose adjustments. 1

Step-by-Step Conversion Algorithm

Step 1: Calculate Total Daily Hydromorphone Dose

  • Sum all hydromorphone doses taken in a 24-hour period 1
  • Include both scheduled and as-needed doses that were actually taken

Step 2: Determine Fentanyl Patch Dose Using Conversion Table

Use the NCCN conversion table directly since hydromorphone is listed 1:

  • 7.5 mg/day oral hydromorphone = 25 mcg/h fentanyl patch
  • 15 mg/day oral hydromorphone = 50 mcg/h fentanyl patch
  • 22.5 mg/day oral hydromorphone = 75 mcg/h fentanyl patch
  • 30 mg/day oral hydromorphone = 100 mcg/h fentanyl patch 1

For doses between these values, round down to the lower patch strength for safety 2.

Step 3: Apply the Patch and Discontinue Hydromorphone

  • Apply the fentanyl patch to intact, non-irritated skin 2
  • Discontinue all scheduled hydromorphone at the time of patch application 1, 2
  • The patch takes 12-24 hours to reach therapeutic levels, so pain control may be suboptimal initially 1

Step 4: Prescribe Breakthrough Medication (Critical)

Prescribe immediate-release oral hydromorphone or morphine for breakthrough pain during the first 8-24 hours 1:

  • Calculate breakthrough dose as 10-15% of the previous total daily hydromorphone dose 1
  • Allow dosing every 1-2 hours as needed 1
  • This is essential because fentanyl levels are still rising during this period 1

Step 5: Monitor and Titrate After Stabilization

Wait at least 2-3 days (one full patch cycle) before making dose adjustments 1:

  • Fentanyl reaches steady-state after 2-3 days 1
  • Track the total amount of breakthrough medication used over 24 hours 1
  • If significant breakthrough medication is needed, increase the patch dose based on the average daily breakthrough requirement 1

Continue breakthrough medication indefinitely even after the patch dose is stabilized 1.

Critical Safety Considerations

Patient Selection Criteria

Only use fentanyl patches in opioid-tolerant patients 1, 2:

  • The FDA defines opioid tolerance as taking at least 60 mg/day oral morphine equivalents for ≥1 week 2
  • Pain must be relatively stable before initiating the patch 1
  • Do NOT use patches for unstable pain requiring frequent dose changes 1

Contraindications and Warnings

Avoid heat exposure (fever, heating pads, electric blankets, heat lamps) as this accelerates fentanyl absorption and can cause overdose 1:

  • Fever is a contraindication to transdermal fentanyl 1

Exercise extreme caution in cachectic patients 3:

  • A case report demonstrated that a patient with cachexia developed opioid toxicity when rotating FROM fentanyl patch, requiring only 30% of the calculated equianalgesic dose 3
  • Cachexia, weight loss, and advanced age can impair patch absorption unpredictably 3

Monitoring Parameters

During the first 72 hours, monitor for:

  • Respiratory depression (respiratory rate, oxygen saturation) 2
  • Sedation level using standardized scales 1
  • Pain control using numeric rating scales 1
  • Opioid withdrawal symptoms if converting from high-dose hydromorphone 1

Common Pitfalls to Avoid

  1. Starting the patch in opioid-naive patients - this can be fatal 2
  2. Failing to provide breakthrough medication during the first 24 hours when fentanyl levels are subtherapeutic 1
  3. Adjusting the patch dose too quickly before steady-state is reached (before 2-3 days) 1
  4. Using patches for unstable or rapidly escalating pain - oral or parenteral opioids are more appropriate 1
  5. Not accounting for heat exposure which can cause rapid, dangerous increases in fentanyl absorption 1

Patch Administration Details

  • Replace patches every 72 hours 1
  • Some patients may require replacement every 48 hours if analgesia wanes before 72 hours 1
  • For doses >100 mcg/h, use multiple patches 2
  • Intermediate strengths (37.5 mcg/h and 62.5 mcg/h) are available for fine-tuning 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.